SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-007386
Filing Date
2021-02-19
Accepted
2021-02-19 16:26:18
Documents
1
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 10140
  Complete submission text file 0000899243-21-007386.txt   11511
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301
Business Address
Harding Thomas C. (Reporting) CIK: 0001834833 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-35347 | Film No.: 21656302